Kairos Pharma
$0.55
0
-$0.01-1.86% Today
Statistics
Day High
0.55
Day Low
0.55
52W High
-
52W Low
-
Volume
3
Avg. Volume
-
Mkt Cap
11.44M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
3JunExpected
Expected EPS
-0.08025
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-5.53MNet Income
Analyst Ratings
$9.00Average Price Target
The highest estimate is 9.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow KAPA.BOATS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Kairos Pharma, Ltd. operates as a clinical-stage biopharmaceutical company that develops therapeutics for cancer patients. Its therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. Kairos Pharma, Ltd. was formerly known as NanoGB13, Inc. and changed its name to Kairos Pharma, Ltd. in July 2016. The company was incorporated in 2013 and is based in Los Angeles, California.
Show more...
CEO
ISIN
US48301N1046
Listings
0 Comments
Share your thoughts
FAQ
What is Kairos Pharma stock price today?▼
The current price of KAPA.BOATS is $0.55 USD — it has decreased by -1.86% in the past 24 hours. Watch Kairos Pharma stock price performance more closely on the chart.
What is Kairos Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Kairos Pharma stocks are traded under the ticker KAPA.BOATS.
What is Kairos Pharma market cap?▼
Today Kairos Pharma has the market capitalization of 11.44M
When is the next Kairos Pharma earnings date?▼
Kairos Pharma is going to release the next earnings report on June 03, 2026.
What were Kairos Pharma earnings last quarter?▼
KAPA.BOATS earnings for the last quarter are -0.02 USD per share, whereas the estimation was -0.02 USD resulting in a +0% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Kairos Pharma revenue for the last year?▼
Kairos Pharma revenue for the last year amounts to 0 USD.
What is Kairos Pharma net income for the last year?▼
KAPA.BOATS net income for the last year is -5.53M USD.
When did Kairos Pharma complete a stock split?▼
Kairos Pharma has not had any recent stock splits.